The P2 purinoceptors in prostate cancer.

Authors:
Wang Z; Zhu S; Tan S; Zeng Y; Zeng H.

Journal:
Purinergic Signal

Publication Year: 2022

DOI:
10.1007/s11302-022-09874-2

PMCID:
PMC9984634

PMID:
35771310

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Purinergic Signal

Abbreviation: Purinergic Signal

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
P2Y<sub>11</sub>/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-…
Klaver D; Thurnher M. (2023) - Transparency Score: 3/6
Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotec…
Fishman P; Stemmer SM; Bareket-Samish A and 2 more (2023) - Transparency Score: 3/6
The P2X7 receptor in mucosal adaptive immunity.
Grassi F; Marino R. (2023) - Transparency Score: 3/6
Burnstock oration - purinergic signalling in kidney transplantation.
Dwyer KM. (2022) - Transparency Score: 3/6
Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmon…
Dales MO; Mitchell C; Gurney AM and 2 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflicts of interestThe authors declare no competing interests. Ethical approvalThis article does not contain any studies with human participants or animals performed by any of the authors. Informed consentNot applicable. Conflicts of interest The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by the Natural Science Foundation of China (NSFC 81,972,502, 81,902,577, 81,974,398, and 82,172,785), Research Foundation for the Postdoctoral Program of Sichuan University (2021SCU12014), and 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (No. ZYJC21020)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025